Return
百曜科技获数千万战略投资，加速AI虚拟细胞产业落地
2026年09月20日 News and Research
近日，中国首家原生AI虚拟细胞（AIVC）平台公司百曜科技快速完成数千万元战略融资。
本次战略融资在一周内完成，旨在快速推进自产数据收集和新型模型研发，加速技术验证与产业落地。未来，百曜科技将进一步深化与产业生态伙伴的协同，加速 AI 虚拟细胞的产业化进程。
Share：
Technology Platform
Model Engine
Application
Applications
Target Discovery
Simulate how genetic and drug interventions affect cell states and functions to identify the key genes, pathways, and regulatory mechanisms driving disease phenotypes, accelerating the discovery, prioritization, and validation of candidate targets.
Cell Simulation
Build virtual cells that respond to genetic, pharmacological, and environmental interventions, simulating state changes, functional responses, and fate transitions across cell types and biological contexts to support cell research and engineering design.
Disease Simulation
Integrate multicellular, multi-omics, spatial microenvironment, and longitudinal disease data to reconstruct disease states and their progression, understand cell–cell interactions and disease heterogeneity, and predict the systemic impact of different intervention strategies.
Case Studies
TME-Based Patient Stratification
Drug Perturbation and Virtual Clinical Trials in the Tumor Microenvironment (TME)
Stem Cell Engineering
AI-Optimized Directed Differentiation Process for Stem Cells
CAR-T Engineering
Genetic Engineering and Functional Optimization of CAR-T Cells
Skin Target Discovery
AI-Driven Discovery of Skin Anti-Aging Targets
